Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Budget slips happen, but you can regain stability with a simple plan. Identify leaks, prioritize essentials, and set a realistic spending cap to regain confidence.
24,983 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Micron Technology fell about 8% in Wednesday trading as investors priced in rising competition from Chinese memory ma...
A growing glut inventory way—how should savvy investors respond when supply rises and loan terms shift? This guide br...
Robotaxi headlines often focus on sensors, AI, and fleet size. The real winner may hinge on an overlooked driver. Thi...
AppLovin led a week of outsized moves in AI-linked shares, with Tempus AI and Micron following suit as memory and sof...
A Massachusetts couple behind EcommerceBytes reached a settlement with eBay in a federal case over years of intimidat...
As Agora releases Q4 2025 data, investors will watch API growth, customer momentum, and profitability signals. This g...
Oscar Health is betting on a 2026 profitability turnaround after a challenging Q4 2025, highlighting AI efficiency, h...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
When a Dentsply Sirona director buys a large block of shares, investors take notice. This article breaks down what th...
Travel demand lifted airline stocks as Delta Air Lines and American Airlines posted upbeat guidance and revenue data ...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...